Outlook Therapeutics Inc
F:41ON
Outlook Therapeutics Inc
F:41ON
Price:
1.537
EUR
-0.84%
Market Closed
Market Cap:
€347.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Outlook Therapeutics Inc
F:41ON
|
US |
|
Sprott Inc
TSX:SII
|
CA |
|
G
|
GlaxoSmithKline PLC
XBER:GS7
|
UK |
|
Arlo Technologies Inc
NYSE:ARLO
|
US |
|
K
|
Kennametal Inc
F:KM3
|
US |
|
Elecnor SA
MAD:ENO
|
ES |
|
Celestica Inc
TSX:CLS
|
CA |
|
D'Ieteren Group NV
XBRU:DIE
|
BE |
|
LG Display Co Ltd
NYSE:LPL
|
KR |
|
Nippon Thompson Co Ltd
TSE:6480
|
JP |
|
Loop Industries Inc
NASDAQ:LOOP
|
CA |
|
L
|
Lagardere SA
XMUN:LAG
|
FR |
|
Sun Life Financial Inc
TSX:SLF
|
CA |
|
Indian Railway Finance Corp Ltd
NSE:IRFC
|
IN |
|
R
|
Royal Caribbean Cruises Ltd
BMV:RCL
|
US |
|
Industria de Diseno Textil SA
MAD:ITX
|
ES |
|
I
|
Ithaca Energy PLC
LSE:ITH
|
UK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 41ON.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
41ON
Multiples-Based Value
Not Available
